Originele publicatiedatum: 12/05/2014 NETHERLANDS ATTRACTIVE FOR PRIVATE EQUITY INVESTMENTS: MID MARKET ENTREPRENEURS NEED TO BETTER FIND THE WAY TO PRIVATE EQUITY PRIVATE EQUITY AND VENTURE CAPITAL INVESTED €2.4 BILLION IN A RECORD
Originele publicatiedatum: 12/05/2014 NETHERLANDS ATTRACTIVE FOR PRIVATE EQUITY INVESTMENTS: MID MARKET ENTREPRENEURS NEED TO BETTER FIND THE WAY TO PRIVATE EQUITY PRIVATE EQUITY AND VENTURE CAPITAL INVESTED €2.4 BILLION IN A RECORD
In de interviewreeks ‘VC in the spotlight’ zetten we venture capitalists in de spotlight. Deze keer interviewen we Janet Nieboer (CEO) & Kostas Mamalingkas (Hoofd Investeringen) van ROM InWest over
Samen met StartGreen organiseerde de Responsible Investment Committee van de NVP een digitaal werkbezoek bij Fairphone. Eva Gouwens (CEO), Noud Tillemans (CFO) en Monique Lempers (Impact Innovation Director) vertelden de
NVP ESSENTIALS VENTURE CAPITAL - AUTUMN 2024 23 SEPTEMBER 2024 Start | 9:00 uur Location | Carlton - Utrecht Cost | €3.150 'My colleagues have often told me that I should follow the NVP Venture
Interview: Melvin Tjoe Nij (Global People) In de samenleving, bij onze (geassocieerde) leden en bij de NVP is er steeds meer aandacht voor “Diversiteit en Inclusie”. In dit kader interviewen we
ADVANCED TRAINING FINANCIAL DUE DILIGENCE: Enterprise to Equity Valuation 16 MEI 2024 & 30 MEI 2024 Tijd | 12:00 (16/5) – 13:00 (30/5) Locatie | Element hotel, Amsterdam
In the interview series 'VC in the spotlight,' we put venture capitalists in the spotlight. This time, we are interviewing Ali Najafbagy from 4impact about sustainability, tech4good, and geopolitical developments.
Sabine Schoorl, senior partner, LUMO Labs: “Steden spelen een cruciale rol bij het veroorzaken en oplossen van klimaatproblemen” 1. Kun je ons iets meer vertellen over jouw studie en loopbaan? En
On Thursday, 6th June 2024, at 16:00, the NVP organizes in collaboration with PwC, a webinar on the Digital Operations Resilience Act (DORA) tailored for PE/VC funds. Content The Digital
'There are still so many game changers waiting in biotech.' Every year, EQT Life Sciences invests in five to ten biotech companies that are working on the most revolutionary technologies, says